HIVE Digital Technologies (HIVE) Stock Rallies Over 50% on AI Gigafactory News

Key Takeaways

• Situational Awareness LP, managed by Leopold Aschenbrenner, disclosed a fresh stake in HIVE during Q1 2026, acquiring approximately 3.4 million shares.
• BUZZ HPC, a HIVE subsidiary, revealed plans on May 18 for a 320 MW AI “gigafactory” located in the Greater Toronto Area, supported by a $58M land purchase and estimated CAD $3.5B in total capital needs.
• Shares jumped 34% on announcement day and eventually rose more than 50% from April’s lows to approximately $4.10.
• Cantor Fitzgerald upgraded its price target to $4.60 from $3 while maintaining an Overweight rating; Northland Securities initiated coverage with a Buy rating.
• Consensus among eight analysts stands at Strong Buy, with an average price target of $6.75—representing approximately 51% potential upside from current trading levels; the street-high target reaches $10.

HIVE Digital Technologies (HIVE) has experienced significant momentum in recent weeks. Between institutional interest from a prominent hedge fund, a transformative infrastructure announcement, and a substantial stock price rally, the company has captured considerable market attention.

HIVE Digital Technologies Ltd., HIVE

On May 18, BUZZ HPC—a subsidiary of HIVE—announced ambitious plans to develop a 320-megawatt AI gigafactory situated in the Greater Toronto Area. To facilitate this massive undertaking, the company secured approximately 25 acres of land through a $58 million acquisition.

When fully operational, this facility is designed to accommodate over 100,000 GPUs. Total capital requirements are estimated at CAD $3.5 billion, with the company targeting a launch during the latter half of 2027.

Investors responded swiftly and decisively. HIVE stock surged 34% by mid-morning trading on May 18, subsequently reaching $3.92—representing approximately 45% appreciation from the May 15 closing price of $2.69.

The upward trajectory continued throughout the following sessions. By May 22, shares settled near $4.10, completing a rally exceeding 50% from April’s trough levels in the $2.24–$2.50 range.

Wall Street Analysts Respond

The Toronto gigafactory announcement prompted immediate reactions from the analyst community. On May 19, Cantor Fitzgerald elevated its price target on HIVE to $4.60 from a previous $3 while reaffirming its Overweight rating.

Analyst Brett Knoblauch highlighted anticipated compute capacity shortages throughout 2026 and 2027 as fundamental catalysts supporting demand for HIVE’s infrastructure capabilities. Importantly, he emphasized that the updated target doesn’t completely incorporate the 320 MW expansion—suggesting additional upside potential remains unaccounted for.

Northland Securities initiated coverage with a Buy rating on the same date.

Among the eight analysts tracking HIVE, the consensus recommendation stands firmly at Strong Buy. The mean price target reaches $6.75, indicating approximately 51% upside potential from present levels. The most optimistic forecast on Wall Street stands at $10.

Institutional Capital Flows

From an institutional perspective, Leopold Aschenbrenner’s Situational Awareness LP revealed a newly established position in HIVE through its Q1 2026 13F regulatory filing. The holding encompasses nearly 3.4 million shares.

Aschenbrenner, a former OpenAI researcher who founded Situational Awareness LP, has become recognized for his strategic focus on AI infrastructure as a compelling long-term investment opportunity.

HIVE’s GPU cloud infrastructure continues expanding toward 11,000 active units. Company leadership has established an Annual Recurring Revenue target of $225 million specifically from high-performance computing operations.

The BUZZ HPC division represents a cornerstone of the investment thesis. This strategic pivot reduces HIVE’s historical dependence on cryptocurrency operations while establishing a more predictable, recurring revenue framework anchored in enterprise AI compute requirements.

HIVE maintains data center facilities across Canada, Sweden, and Paraguay. The company’s shares trade on both the Nasdaq and TSX exchanges under the HIVE ticker symbol.

Full fiscal year 2026 financial results are scheduled for release on June 1, followed by a management earnings call on June 2.